Trimester-specific association of gestational Atherogenic Index of Plasma (AIP) with adverse pregnancy outcomes among women with and without GDM: a cohort study

Atherogenic Index of Plasma (AIP) is a well-recognized marker for cardiovascular disease (CVD), however, its impact on adverse pregnancy outcomes (APOs) has been rarely explored, with particular uncertainty about whether the associations differ between women with and without gestational diabetes mellitus (GDM). Pregnant women were recruited between 24 and 28 gestational weeks at Ma’anshan maternal and child health care center (Anhui Province, China) from June 2021 to December 2022. AIP values we